JERRET KOLESAR: Open Payments
NPI 1104558840 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 29 payments from 8 companies in 2025. Trend: 2023 $19 · 2024 $160 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $250 |
| Axsome Therapeutics, Inc. | 5 | $210 |
| ABBVIE INC. | 4 | $61 |
| Indivior Inc. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: CAPLYTA, Auvelity, VRAYLAR, SUBLOCADE, FANAPT, REXULTI, SPRAVATO, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
